[Debate concerning the optimal blockage of the renin-angiotensin system].
作者信息
Choukroun G
机构信息
CHU d'Amiens, Hôpital Sud - Néphrologie, Médecine Interne, Dialyse, Transplantation et Réanimation Médicale, Avenue René Laënnec-Salouël, 80054 Amiens cedex 1, France.
出版信息
Nephrol Ther. 2010 Jan;6 Spec No 1:H1-9. doi: 10.1016/S1769-7255(10)70001-8.
Abstract
摘要
相似文献
1
[Debate concerning the optimal blockage of the renin-angiotensin system].[关于肾素-血管紧张素系统最佳阻断的辩论]
Nephrol Ther. 2010 Jan;6 Spec No 1:H1-9. doi: 10.1016/S1769-7255(10)70001-8.
2
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.联合使用血管紧张素转换酶抑制剂和血管紧张素II 1型受体拮抗剂对肾素-血管紧张素系统进行阻断。
Circulation. 2004 Jun 1;109(21):2492-9. doi: 10.1161/01.CIR.0000131449.94713.AD.
3
[Renin inhibition and the kidney].[肾素抑制与肾脏]
Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:28-31.
4
Recent changes in the landscape of combination RAS blockade.联合RAS阻断领域的近期变化。
Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127.
5
Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.阿利吉仑：一种新型肾素-血管紧张素-醛固酮系统活性抑制剂。
Minerva Endocrinol. 2009 Dec;34(4):333-8.
6
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.肾素 - 血管紧张素系统阻断与慢性肾脏病合并蛋白尿患者的心血管结局：一项荟萃分析。
Am Heart J. 2008 May;155(5):791-805. doi: 10.1016/j.ahj.2008.01.031.
7
Angiotensin II type 1 receptor blockade: high hopes sent back to reality?血管紧张素II 1型受体阻断：厚望重归现实？
Minerva Cardioangiol. 2009 Dec;57(6):773-85.
8
Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?在慢性心力衰竭和急性心肌梗死中应使用哪种肾素-血管紧张素系统抑制剂？
Circulation. 2004 Nov 16;110(20):3281-8. doi: 10.1161/01.CIR.0000147274.83071.68.
9
Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?糖尿病和非糖尿病慢性肾脏病中通过阻断肾素-血管紧张素-醛固酮系统实现的肾脏保护作用。肾内血管紧张素转换酶活性在治疗抵抗中的具体作用？
Minerva Med. 2004 Oct;95(5):395-409.
10
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?肾素-血管紧张素系统抑制对靶器官保护的作用：我们能否做得更好？
Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019.
Zotero 插件